ARS PHARMACEUTICALS INC(SPRY)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

SPRY ARS PHARMACEUTICALS INC

交易中 07-18 10:24:37 EDT

11.55

+0.22

+1.94%

最高11.60	最低11.24	成交量2.91万
今开11.34	昨收11.33	日振幅3.13%
总市值11.19亿	流通市值4.97亿	总股本9,690万
成交额33.13万	换手率0.07%	流通股本4,303万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"SPRY","market":"US","secType":"STK","nameCN":"ARS PHARMACEUTICALS INC","latestPrice":11.55,"timestamp":1721312668587,"preClose":11.33,"halted":0,"volume":29064,"delay":0,"floatShares":43028886,"shares":96895256,"eps":-0.518855,"marketStatus":"交易中","marketStatusCode":2,"change":0.22,"latestTime":"07-18 10:24:37 EDT","open":11.34,"high":11.595,"low":11.2401,"amount":331305.302496,"amplitude":0.031324,"askPrice":11.54,"askSize":27,"bidPrice":11.52,"bidSize":102,"shortable":3,"etf":0,"ttmEps":-0.518855,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1721332800000},"adr":0,"listingDate":1607058000000,"adjPreClose":11.33,"preHourTrading":{"tag":"盘前","latestPrice":11.36,"preClose":11.33,"latestTime":"09:29 EDT","volume":280,"amount":3175.2798,"timestamp":1721309399999},"postHourTrading":{"tag":"盘后","latestPrice":11.3,"preClose":11.33,"latestTime":"19:32 EDT","volume":31836,"amount":360659.58,"timestamp":1721259124782},"volumeRatio":0.258801,"impliedVol":0.7241,"impliedVolPercentile":0.2143},"requestUrl":"/m/hq/s/SPRY/wiki","defaultTab":"wiki","newsList":[{"id":"2450398057","title":"Ars Pharmaceuticals, Inc.盘中异动 股价大涨5.07%报10.99美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450398057","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450398057?lang=zh_cn&edition=full","pubTime":"2024-07-12 00:16","pubTimestamp":1720714614,"startTime":"0","endTime":"0","summary":"北京时间2024年07月12日00时16分，Ars Pharmaceuticals, Inc.股票出现波动，股价大幅拉升5.07%。Ars Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.43%。其相关个股中，Neximmune, Inc.、Biodexa Pharmaceuticals Plc、Kazia Therapeutics Limited涨幅较大，Neximmune, Inc.、Biodexa Pharmaceuticals Plc、Kazia Therapeutics Limited较为活跃，换手率分别为839.12%、642.61%、613.69%，振幅较大的相关个股有Neximmune, Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Geovax Labs Inc C/Wts 29/09/2025，振幅分别为172.94%、149.14%、97.11%。Ars Pharmaceuticals, Inc.公司简介：ARS Pharmaceuticals Inc是一家生物制药公司，专注于开发用于紧急治疗 I 型过敏反应的新型、潜在全新候选产品 neffy。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712001655aef94201&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712001655aef94201&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRY","BK4139"],"gpt_icon":0},{"id":"2450818288","title":"Ars Pharmaceuticals, Inc.盘中异动 急速上涨5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450818288","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450818288?lang=zh_cn&edition=full","pubTime":"2024-07-10 21:44","pubTimestamp":1720619076,"startTime":"0","endTime":"0","summary":"北京时间2024年07月10日21时44分，Ars Pharmaceuticals, Inc.股票出现波动，股价快速上涨5.23%。Ars Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.05%。其相关个股中，Virpax Pharmaceuticals, Inc.、Longeveron Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026涨幅较大，Virpax Pharmaceuticals, Inc.、Soligenix, Inc.、Longeveron Inc.较为活跃，换手率分别为1631.82%、813.60%、485.86%，振幅较大的相关个股有Virpax Pharmaceuticals, Inc.、Kazia Therapeutics Limited、Longeveron Inc.，振幅分别为119.83%、62.50%、59.23%。Ars Pharmaceuticals, Inc.公司简介：ARS Pharmaceuticals Inc是一家生物制药公司，专注于开发用于紧急治疗 I 型过敏反应的新型、潜在全新候选产品 neffy。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710214436941f5d51&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710214436941f5d51&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LGVN","BK4007","SPRY","VRPX"],"gpt_icon":0},{"id":"2450508385","title":"Ars Pharmaceuticals, Inc.盘中异动 快速拉升5.05%报9.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450508385","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450508385?lang=zh_cn&edition=full","pubTime":"2024-07-09 00:52","pubTimestamp":1720457572,"startTime":"0","endTime":"0","summary":"北京时间2024年07月09日00时52分，Ars Pharmaceuticals, Inc.股票出现异动，股价快速拉升5.05%。Ars Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.69%。其相关个股中，Virpax Pharmaceuticals, Inc.、Morphic Holding, Inc.、Revelation Biosciences Inc C/Wts 10/01/2027 涨幅较大，Virpax Pharmaceuticals, Inc.、Cero Therapeutics Holdings, Inc.、Kineta, Inc.较为活跃，换手率分别为4951.76%、199.35%、174.42%，振幅较大的相关个股有Virpax Pharmaceuticals, Inc.、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Annovis Bio, Inc.，振幅分别为121.11%、80.23%、56.04%。Ars Pharmaceuticals, Inc.公司简介：ARS Pharmaceuticals Inc是一家生物制药公司，专注于开发用于紧急治疗 I 型过敏反应的新型、潜在全新候选产品 neffy。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240709005252af911afd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240709005252af911afd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","SPRY","BK4139","VRPX"],"gpt_icon":0},{"id":"2448509489","title":"Ars Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.77%报9.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448509489","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448509489?lang=zh_cn&edition=full","pubTime":"2024-07-03 22:08","pubTimestamp":1720015730,"startTime":"0","endTime":"0","summary":"北京时间2024年07月03日22时08分，Ars Pharmaceuticals, Inc.股票出现异动，股价快速拉升5.77%。Ars Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.59%。Ars Pharmaceuticals, Inc.公司简介：ARS Pharmaceuticals Inc是一家生物制药公司，专注于开发用于紧急治疗 I 型过敏反应的新型、潜在全新候选产品 neffy。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703220850af9066ce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703220850af9066ce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRY","BK4139"],"gpt_icon":0},{"id":"2446688417","title":"Ars Pharmaceuticals, Inc.盘中异动 股价大涨5.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446688417","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446688417?lang=zh_cn&edition=full","pubTime":"2024-06-28 21:30","pubTimestamp":1719581430,"startTime":"0","endTime":"0","summary":"北京时间2024年06月28日21时30分，Ars Pharmaceuticals, Inc.股票出现异动，股价急速上涨5.47%。Ars Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.69%。其相关个股中，Revolution Medicines Inc C/Wts 17/12/2026 、180 Life Sciences Corp C/Wts 07/11/2025、Clearmind Medicine Inc.涨幅较大，Clearmind Medicine Inc.、Carisma Therapeutics, Inc.、Geovax Labs, Inc.较为活跃，换手率分别为174.06%、16.28%、13.40%，振幅较大的相关个股有Cero Therapeutics Holdings, Inc.、Dyadic International, Inc.、Ginkgo Bioworks Holdings, Inc.，振幅分别为4.76%、3.80%、2.23%。Ars Pharmaceuticals, Inc.公司简介：ARS Pharmaceuticals Inc是一家生物制药公司，专注于开发用于紧急治疗 I 型过敏反应的新型、潜在全新候选产品 neffy。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062821303096817fd3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062821303096817fd3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SPRY"],"gpt_icon":0},{"id":"2446502599","title":"BUZZ-欧盟监管机构建议批准鼻腔喷雾剂，ARS 制药公司业绩攀升","url":"https://stock-news.laohu8.com/highlight/detail?id=2446502599","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446502599?lang=zh_cn&edition=full","pubTime":"2024-06-28 20:49","pubTimestamp":1719578975,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    6月28日 - ** 药物开发商ARS Pharmaceuticals   股价盘前上涨4.8%至8.44美元** 该公司称，欧洲药品管理局(EMA) 建议 (link) 批准其治疗过敏反应的无针紧急疗法 EURneffy** ARS称，欧盟执委会通常遵循EMA的建议，预计将于2024年第三季度就EURNEFFY作出决定。** 美国食品和药物管理局也在审查该鼻腔喷雾剂，预计将于 10 月 2 日做出决定** 截至上次收盘，股价累计上涨 46.9","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BUZZ","SPRY","BK4139"],"gpt_icon":0},{"id":"2446954570","title":"欧盟监管机构建议批准 ARS 制药公司的喷鼻剂替代 EpiPen","url":"https://stock-news.laohu8.com/highlight/detail?id=2446954570","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446954570?lang=zh_cn&edition=full","pubTime":"2024-06-28 18:57","pubTimestamp":1719572253,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    路透6月28日 - ARS制药公司  周五称，欧洲药品管理局(EMA) 建议批准其治疗过敏反应的无针紧急疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SPRY"],"gpt_icon":0},{"id":"2434830336","title":"ARS Pharmaceuticals Inc   预计每股亏损13美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2434830336","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434830336?lang=zh_cn&edition=full","pubTime":"2024-05-10 19:43","pubTimestamp":1715341420,"startTime":"0","endTime":"0","summary":"   * ARS Pharmaceuticals Inc    预计将在8月8日公布截至2024年6月30日的季度业绩(估计)，季度收入将有所增长。* LSEG 分析师对 ARS 制药公司的平均预期是每股亏损 13 美分。* 华尔街对 ARS Pharmaceuticals Inc 的 12 个月目标价中位数为 19.00 美元，高于其最新收盘价 8.80 美元。5月10日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPRY"],"gpt_icon":0},{"id":"2432502563","title":"Ars Pharmaceuticals, Inc.盘中异动 股价大涨5.29%报9.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432502563","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432502563?lang=zh_cn&edition=full","pubTime":"2024-05-01 23:04","pubTimestamp":1714575863,"startTime":"0","endTime":"0","summary":"北京时间2024年05月01日23时04分，Ars Pharmaceuticals, Inc.股票出现异动，股价急速拉升5.29%。Ars Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.76%。其相关个股中，Cytomx Therapeutics, Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Palisade Bio, Inc.涨幅较大，Palisade Bio, Inc.、Cytomx Therapeutics, Inc.、Cyclacel Pharmaceuticals, Inc.较为活跃，换手率分别为1255.88%、167.99%、40.19%，振幅较大的相关个股有Cytomx Therapeutics, Inc.、Cassava Sciences Inc C/Wts 15/11/2024、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 ，振幅分别为188.34%、66.20%、54.57%。Ars Pharmaceuticals, Inc.公司简介：ARS Pharmaceuticals Inc是一家生物制药公司，专注于开发用于紧急治疗 I 型过敏反应的新型、潜在全新候选产品 neffy。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405012304237a57dd55&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405012304237a57dd55&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SPRY"],"gpt_icon":0},{"id":"2430054292","title":"Ars Pharmaceuticals, Inc.盘中异动 股价大涨5.19%报8.51美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430054292","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2430054292?lang=zh_cn&edition=full","pubTime":"2024-04-26 22:12","pubTimestamp":1714140777,"startTime":"0","endTime":"0","summary":"北京时间2024年04月26日22时12分，Ars Pharmaceuticals, Inc.股票出现异动，股价急速拉升5.19%。Ars Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.18%。其相关个股中，Biodexa Pharmaceuticals Plc、Cassava Sciences Inc C/Wts 15/11/2024、Protagenic Therapeutics Inc C/Wts 29/04/2026 涨幅较大，Biodexa Pharmaceuticals Plc、Kintara Therapeutics, Inc.、Processa Pharmaceuticals, Inc.较为活跃，换手率分别为975.06%、96.37%、32.79%，振幅较大的相关个股有Biodexa Pharmaceuticals Plc、Cassava Sciences Inc C/Wts 15/11/2024、Tevogen Bio Holdings Inc.，振幅分别为73.12%、66.85%、30.07%。Ars Pharmaceuticals, Inc.公司简介：ARS Pharmaceuticals Inc是一家生物制药公司，专注于开发用于紧急治疗 I 型过敏反应的新型、潜在全新候选产品 neffy。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404262212577923fdbd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404262212577923fdbd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SPRY"],"gpt_icon":0},{"id":"2430128560","title":"Ars Pharmaceuticals, Inc.盘中异动 股价大跌6.90%报7.69美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430128560","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2430128560?lang=zh_cn&edition=full","pubTime":"2024-04-25 21:36","pubTimestamp":1714052189,"startTime":"0","endTime":"0","summary":"北京时间2024年04月25日21时36分，Ars Pharmaceuticals, Inc.股票出现波动，股价快速下挫6.90%。Ars Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.71%。其相关个股中，Processa Pharmaceuticals, Inc.、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Zura Bio Limited C/Wts 涨幅较大，Processa Pharmaceuticals, Inc.、Cyclacel Pharmaceuticals, Inc.、Cidara Therapeutics, Inc.较为活跃，换手率分别为786.98%、182.46%、6.74%，振幅较大的相关个股有Cassava Sciences Inc C/Wts 15/11/2024、Processa Pharmaceuticals, Inc.、凯信远达，振幅分别为40.85%、23.46%、14.75%。Ars Pharmaceuticals, Inc.公司简介：ARS Pharmaceuticals Inc是一家生物制药公司，专注于开发用于紧急治疗 I 型过敏反应的新型、潜在全新候选产品 neffy。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042521362987e83b14&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042521362987e83b14&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SPRY"],"gpt_icon":0},{"id":"2429011630","title":"Ars Pharmaceuticals, Inc.盘中异动 早盘大幅上涨5.06%报8.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429011630","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2429011630?lang=zh_cn&edition=full","pubTime":"2024-04-23 22:39","pubTimestamp":1713883146,"startTime":"0","endTime":"0","summary":"北京时间2024年04月23日22时39分，Ars Pharmaceuticals, Inc.股票出现异动，股价快速上涨5.06%。Ars Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.55%。其相关个股中，Revolution Medicines Inc C/Wts 17/12/2026 、Nkgen Biotech Inc C/Wts 31/05/2028、Palisade Bio, Inc.涨幅较大，Palisade Bio, Inc.、Silo Pharma, Inc.、Nkgen Biotech, Inc.较为活跃，换手率分别为2326.94%、174.75%、34.21%，振幅较大的相关个股有Palisade Bio, Inc.、Moolec Science Sa C/Wts 、Immunitybio, Inc.，振幅分别为45.43%、38.82%、27.32%。Ars Pharmaceuticals, Inc.公司简介：ARS Pharmaceuticals Inc是一家生物制药公司，专注于开发用于紧急治疗 I 型过敏反应的新型、潜在全新候选产品 neffy。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404232239077a54f172&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404232239077a54f172&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRY","BK4139"],"gpt_icon":0},{"id":"2426197952","title":"Ars Pharmaceuticals, Inc.盘中异动 股价大跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426197952","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2426197952?lang=zh_cn&edition=full","pubTime":"2024-04-09 21:44","pubTimestamp":1712670263,"startTime":"0","endTime":"0","summary":"北京时间2024年04月09日21时44分，Ars Pharmaceuticals, Inc.股票出现波动，股价大幅下挫5.04%。Ars Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.01%。其相关个股中，Acrivon Therapeutics, Inc.、Biophytis、Mymd Pharmaceuticals, Inc.涨幅较大，Mymd Pharmaceuticals, Inc.、Biophytis、Acrivon Therapeutics, Inc.较为活跃，换手率分别为344.54%、87.97%、40.57%，振幅较大的相关个股有Biophytis、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Mymd Pharmaceuticals, Inc.，振幅分别为24.30%、19.66%、18.68%。Ars Pharmaceuticals, Inc.公司简介：ARS Pharmaceuticals Inc 是一家生物制药公司，专注于开发用于紧急治疗 I 型过敏反应的新型、潜在一流候选产品 neffy。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240409214423791f6b24&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240409214423791f6b24&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRY","BK4139"],"gpt_icon":0},{"id":"2422612657","title":"Ars Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422612657","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2422612657?lang=zh_cn&edition=full","pubTime":"2024-03-26 22:42","pubTimestamp":1711464133,"startTime":"0","endTime":"0","summary":"北京时间2024年03月26日22时42分，Ars Pharmaceuticals, Inc.股票出现波动，股价快速拉升5.04%。Ars Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.12%。其相关个股中，Nutriband Inc C/Wts 、Stoke Therapeutics, Inc.、Artelo Biosciences Inc C/Wts 20/06/2024 涨幅较大，Abvc Biopharma, Inc.、Altamira Therapeutics Ltd.、Stoke Therapeutics, Inc.较为活跃，换手率分别为210.44%、29.26%、28.91%，振幅较大的相关个股有Nutriband Inc C/Wts 、Stoke Therapeutics, Inc.、Mesoblast Ltd，振幅分别为130.19%、34.92%、32.27%。Ars Pharmaceuticals, Inc.公司简介：ARS Pharmaceuticals Inc 是一家生物制药公司，专注于开发用于紧急治疗 I 型过敏反应的新型、潜在一流候选产品 neffy。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240326224213861e1452&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240326224213861e1452&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRY","BK4139"],"gpt_icon":0},{"id":"2422364543","title":"Ars Pharmaceuticals, Inc.盘中异动 大幅上涨5.09%报9.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422364543","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2422364543?lang=zh_cn&edition=full","pubTime":"2024-03-25 21:55","pubTimestamp":1711374927,"startTime":"0","endTime":"0","summary":"北京时间2024年03月25日21时55分，Ars Pharmaceuticals, Inc.股票出现波动，股价急速拉升5.09%。Ars Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.23%。其相关个股中，Landos Biopharma, Inc.、Altamira Therapeutics Ltd.、Xtl生物制药涨幅较大，Altamira Therapeutics Ltd.、Xtl生物制药、Salarius Pharmaceuticals, Inc.较为活跃，换手率分别为1926.79%、116.87%、57.87%，振幅较大的相关个股有Xtl生物制药、Altamira Therapeutics Ltd.、Brainstorm Cell Therapeutics Inc.，振幅分别为71.37%、47.40%、26.61%。Ars Pharmaceuticals, Inc.公司简介：ARS Pharmaceuticals Inc 是一家生物制药公司，专注于开发用于紧急治疗 I 型过敏反应的新型、潜在一流候选产品 neffy。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032521552787e7b7d1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032521552787e7b7d1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRY","BK4139"],"gpt_icon":0},{"id":"2421070657","title":"ARS 制药公司公布截至 12 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2421070657","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2421070657?lang=zh_cn&edition=full","pubTime":"2024-03-22 05:12","pubTimestamp":1711055556,"startTime":"0","endTime":"0","summary":"   * ARS Pharmaceuticals Inc   报告，在截至12月底的季度调整后每股亏损7美分，低于去年同期的每股收益77美分。三位分析师对该季度的平均预期是每股亏损 14 美分。华尔街预期为每股-17美分至-11美分。* ARS Pharmaceuticals Inc 公布的季度每股收益为亏损 7 美分。* ARS Pharmaceuticals Inc 的股价本季度上涨了 58.8%。华尔街对 ARS 制药公司 12 个月目标价的中位数为 18.50 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPRY","BK4139"],"gpt_icon":0},{"id":"2420279302","title":"Ars Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2420279302","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2420279302?lang=zh_cn&edition=full","pubTime":"2024-03-19 23:09","pubTimestamp":1710860941,"startTime":"0","endTime":"0","summary":"北京时间2024年03月19日23时09分，Ars Pharmaceuticals, Inc.股票出现波动，股价快速下跌5.10%。Ars Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。其相关个股中，Fusion Pharmaceuticals Inc.、Moolec Science Sa C/Wts 、180 Life Sciences Corp C/Wts 07/11/2025涨幅较大，Enveric Biosciences, Inc.、Hoth Therapeutics, Inc.、Clearmind Medicine Inc.较为活跃，换手率分别为831.46%、407.14%、136.58%，振幅较大的相关个股有Enveric Biosciences, Inc.、知临集团、Tracon Pharmaceuticals, Inc.，振幅分别为56.00%、49.87%、47.94%。Ars Pharmaceuticals, Inc.公司简介：ARS Pharmaceuticals Inc 是一家生物制药公司，专注于开发用于紧急治疗 I 型过敏反应的新型、潜在一流候选产品 neffy。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240319230901791b7c25&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240319230901791b7c25&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRY","BK4139"],"gpt_icon":0},{"id":"2420624430","title":"ARS Pharmaceuticals Inc   预计每股亏损14美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2420624430","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2420624430?lang=zh_cn&edition=full","pubTime":"2024-03-19 19:02","pubTimestamp":1710846175,"startTime":"0","endTime":"0","summary":"   * ARS Pharmaceuticals Inc    预计在3月21日公布截至2023年12月31日的业绩时，季度收入将出现下降(预计)。*    * LSEG分析师对ARS Pharmaceuticals Inc的平均预期是每股亏损14美分。* 华尔街对 ARS Pharmaceuticals Inc 的 12 个月目标价中位数为 18.50 美元，高于其最新收盘价 9.12 美元。3月19日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPRY"],"gpt_icon":0},{"id":"2419663630","title":"Ars Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2419663630","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2419663630?lang=zh_cn&edition=full","pubTime":"2024-03-13 22:47","pubTimestamp":1710341277,"startTime":"0","endTime":"0","summary":"北京时间2024年03月13日22时47分，Ars Pharmaceuticals, Inc.股票出现波动，股价快速拉升5.02%。Ars Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.04%。其相关个股中，Estrella Immunopharma Inc C/Wts 29/09/2028、Nucana Plc、Tc Biopharm  Plc C/Wts 10/02/2028 涨幅较大，Kintara Therapeutics, Inc.、Nucana Plc、Tc Biopharm  Plc较为活跃，换手率分别为224.64%、71.68%、38.47%，振幅较大的相关个股有180 Life Sciences Corp C/Wts 07/11/2025、Tc Biopharm  Plc C/Wts 10/02/2028 、Nucana Plc，振幅分别为82.54%、66.67%、52.21%。Ars Pharmaceuticals, Inc.公司简介：ARS Pharmaceuticals Inc 是一家生物制药公司，专注于开发用于紧急治疗 I 型过敏反应的新型、潜在一流候选产品 neffy。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403132247577a4c57a8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403132247577a4c57a8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SPRY"],"gpt_icon":0},{"id":"2418397788","title":"Ars Pharmaceuticals, Inc.盘中异动 临近收盘股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2418397788","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2418397788?lang=zh_cn&edition=full","pubTime":"2024-03-12 03:39","pubTimestamp":1710185971,"startTime":"0","endTime":"0","summary":"北京时间2024年03月12日03时39分，Ars Pharmaceuticals, Inc.股票出现异动，股价大幅下跌5.01%。Ars Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.28%。其相关个股中，Aslan Pharmaceuticals Limited、Tc Biopharm  Plc C/Wts 10/02/2028 、Celularity Inc C/Wts 16/07/2026 涨幅较大，Tc Biopharm  Plc、180 Life Sciences Corp.、Transcode Therapeutics, Inc.较为活跃，换手率分别为5677.46%、196.41%、119.55%，振幅较大的相关个股有Aslan Pharmaceuticals Limited、Tc Biopharm  Plc、Tc Biopharm  Plc C/Wts 10/02/2028 ，振幅分别为203.84%、152.82%、145.83%。Ars Pharmaceuticals, Inc.公司简介：ARS Pharmaceuticals Inc 是一家生物制药公司，专注于开发用于紧急治疗 I 型过敏反应的新型、潜在一流候选产品 neffy。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031203393187e77d58&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031203393187e77d58&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SPRY"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ars-pharma.com","stockEarnings":[{"period":"1week","weight":0.0832},{"period":"1month","weight":0.3472},{"period":"3month","weight":0.3424},{"period":"6month","weight":0.8727},{"period":"1year","weight":0.6071},{"period":"ytd","weight":1.0675}],"compareEarnings":[{"period":"1week","weight":-0.0078},{"period":"1month","weight":0.018},{"period":"3month","weight":0.115},{"period":"6month","weight":0.1544},{"period":"1year","weight":0.2262},{"period":"ytd","weight":0.1717}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"ARS Pharmaceuticals, Inc.于2016年1月4日根据特拉华州法律成立。ARS是一家生物制药公司，专注于开发新型的、可能是一流产品的候选产品neffy（以前称为ARS-1），用于I型过敏反应的紧急治疗，包括过敏反应。neffy是一种肾上腺素的专利组合物，带有一种名为Intravail的创新吸收增强剂，可以让neffy在小剂量、易于携带、易于使用、快速给药和可靠的鼻喷雾剂中，以低剂量提供类似注射的肾上腺素吸收。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.09589},{"month":2,"riseRate":0.75,"avgChangeRate":0.156334},{"month":3,"riseRate":0.25,"avgChangeRate":-0.081262},{"month":4,"riseRate":0,"avgChangeRate":-0.132409},{"month":5,"riseRate":0.75,"avgChangeRate":0.018154},{"month":6,"riseRate":0.5,"avgChangeRate":0.064481},{"month":7,"riseRate":0.75,"avgChangeRate":0.156406},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.084853},{"month":9,"riseRate":0,"avgChangeRate":-0.347544},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.004265},{"month":11,"riseRate":0.333333,"avgChangeRate":0.055847},{"month":12,"riseRate":0.666667,"avgChangeRate":0.151109}],"exchange":"NASDAQ","name":"ARS PHARMACEUTICALS INC","nameEN":"ARS PHARMACEUTICALS INC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ARS PHARMACEUTICALS INC(SPRY)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供ARS PHARMACEUTICALS INC(SPRY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"ARS PHARMACEUTICALS INC,SPRY,ARS PHARMACEUTICALS INC股票,ARS PHARMACEUTICALS INC股票老虎,ARS PHARMACEUTICALS INC股票老虎国际,ARS PHARMACEUTICALS INC行情,ARS PHARMACEUTICALS INC股票行情,ARS PHARMACEUTICALS INC股价,ARS PHARMACEUTICALS INC股市,ARS PHARMACEUTICALS INC股票价格,ARS PHARMACEUTICALS INC股票交易,ARS PHARMACEUTICALS INC股票购买,ARS PHARMACEUTICALS INC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ARS PHARMACEUTICALS INC(SPRY)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供ARS PHARMACEUTICALS INC(SPRY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况